600165 *ST寧科生物
按盤價 
2.200 -0.120 (-5.172%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 527.242 | -116.790 | -20.217 | -19.240 | 2.250 |
| 總資產報酬率 ROA (%) | -18.550 | -14.929 | -4.298 | -5.002 | 0.749 |
| 投入資產回報率 ROIC (%) | -37.413 | -23.967 | -6.126 | -6.613 | 0.774 | 邊際利潤分析 |
| 銷售毛利率 (%) | -0.349 | -34.930 | 11.112 | -32.934 | 9.223 |
| 營業利潤率 (%) | -261.941 | -173.002 | -23.775 | -74.861 | 2.226 |
| 息稅前利潤/營業總收入 (%) | -209.728 | -131.109 | -11.173 | -62.638 | 36.110 |
| 淨利潤/營業總收入 (%) | -270.382 | -180.667 | -24.974 | -76.166 | 19.478 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 33.755 | 60.974 | 89.969 | 93.760 | -206.382 |
| 價值變動淨收益/利潤總額(%) | 49.435 | -6.619 | -21.092 | -21.262 | 208.018 |
| 營業外收支淨額/利潤總額(%) | 3.081 | 4.295 | 2.297 | 0.459 | 86.789 | 償債能力分析 |
| 流動比率 (X) | 0.161 | 0.110 | 0.161 | 0.289 | 0.630 |
| 速動比率 (X) | 0.089 | 0.057 | 0.091 | 0.155 | 0.560 |
| 資產負債率 (%) | 107.006 | 87.084 | 72.731 | 67.822 | 61.827 |
| 帶息債務/全部投入資本 (%) | 74.150 | 57.311 | 46.679 | 40.677 | -- |
| 股東權益/帶息債務 (%) | -54.499 | 17.249 | 61.656 | 77.844 | 88.936 |
| 股東權益/負債合計 (%) | -14.772 | 6.518 | 26.390 | 34.358 | 46.377 |
| 利息保障倍數 (X) | -3.464 | -2.640 | -0.849 | -4.984 | 1.875 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.992 | 56.537 | 13.795 | 47.113 | 0.000 |
| 存貨周轉天數 (天) | 163.571 | 95.789 | 75.598 | 122.267 | 0.000 |
| 備註： | 即時報價更新時間為 15/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
